Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Download PDF
Dtsch Med Wochenschr 2005; 130(14): 903
DOI: 10.1055/s-2005-865107
DOI: 10.1055/s-2005-865107
Fragen aus der Praxis
© Georg Thieme Verlag Stuttgart · New York
Proinsulin als Marker - wofür?
Further Information
Publication History
Publication Date:
30 March 2005 (online)
Frage: Welche Aussagen lassen sich mit der Untersuchung von Proinsulin treffen?
Literatur
- 1
Fort T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Pfützner A.
Fasting Intact Proinsulin is a highly specific Indicator of Insulin Resistance in
Type 2 Diabetes.
Diabetes.
2003;
52
(Suppl 1)
A459
MissingFormLabel
- 2
Kubo K.
Effect of Pioglitazone on blood proinsulin levels in patients with type 2 diabetes.
Endocrine Journal.
2002;
49
323-328
MissingFormLabel
- 3
Pfützner A, Kunt T, Mondok A, Pahler S, Konrad T, Luebben G, Forst T.
Fasting Intact Proinsulin is a Highly Specific Predictor of Insulin Resistance in
Typ 2 Diabetes.
Diabetes Care.
2004;
27
682-686
MissingFormLabel
- 4
Yudkin J S, May M, Elwood P, Yarnell J W, Greenwood R, Davey S G.
Concentrations of proinsulin-like-molecules predict coronary heart disease risk independently
of insulin: prospective data from the Caerphilly study.
Diabetologia.
2002;
45
327-336
MissingFormLabel
- 5 Mitteilung der Fa. Sciema GmbH, D-55116 Mainz (www.sciema.de)
MissingFormLabel
OA Dr. T. Kayser
Internist u. Gastroenterologe, Diabetologe DDG, Städtische Kliniken Esslingen a. N.,
Klinik für Innere Medizin I/Fachbereich Gastroenterologie
Hirschlandstraße 97
73730 Esslingen